Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LXRX Lexicon Pharmaceuticals

Market Closed 11-06 16:00:00 EST

1.78

+0.17

+10.56%

盘后1.78

+0.000.00%

19:59 EST

High1.84	Low1.61	Vol3.60M
Open1.66	D1 Closing1.61	Amplitude14.29%
Mkt Cap790.32M	Tradable Cap392.34M	Total Shares444.00M
T/O6.34M	T/O Rate1.63%	Tradable Shares220.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"Lexicon Pharmaceuticals","latestPrice":1.78,"timestamp":1793998800000,"preClose":1.61,"halted":0,"volume":3601340,"hourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.78,"latestTime":"19:59 EST","volume":7513,"amount":13355.4002,"timestamp":1794013142169,"change":0,"changeRate":0,"amplitude":0.016854},"delay":0,"changeRate":0.10559006211180119,"floatShares":220415134,"shares":444000000,"eps":-0.158737,"marketStatus":"Market Closed","change":0.17,"latestTime":"11-06 16:00:00 EST","open":1.66,"high":1.84,"low":1.61,"amount":6341591.683052,"amplitude":0.142857,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.158737,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":1.61,"preHourTrading":{"tag":"盘前","latestPrice":1.61,"preClose":1.61,"latestTime":"09:28 EST","volume":192,"amount":307.57002239999997,"timestamp":1793975317080,"change":0,"changeRate":0,"amplitude":0.006211},"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.78,"latestTime":"19:59 EST","volume":7513,"amount":13355.4002,"timestamp":1794013142169,"change":0,"changeRate":0,"amplitude":0.016854},"volumeRatio":1.6009995766362375,"impliedVol":2.0157,"impliedVolPercentile":0.9283},"requestUrl":"/m/hq/s/LXRX","defaultTab":"news","newsList":[{"id":"2681006691","title":"Lexicon Pharmaceuticals, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681006691","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681006691?lang=en_us&edition=fundamental","pubTime":"2026-11-06 02:45","pubTimestamp":1793904324,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings SummaryLexicon Pharmaceuticals, Inc.LXRX.OQreported a quarterly adjusted loss of 3 cents per share for the q","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL5N46M2WR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681933077","title":"Analysts Are Bullish on These Healthcare Stocks: Summit Therapeutics (SMMT), Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681933077","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681933077?lang=en_us&edition=fundamental","pubTime":"2026-11-05 23:30","pubTimestamp":1793892614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT) and Lexicon Pharmaceutica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-summit-therapeutics-smmt-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-summit-therapeutics-smmt-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","LABU","XBI","BK4137","BK4007","LU0128526141.USD","LU2488822045.USD","LXRX","BK4585","BK4581","XLV","BK4588","LU0029874061.USD","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681078623","title":"Lexicon Pharmaceuticals Q3 EPS $(0.03) Beats $(0.06) Estimate, Sales $11.250M Beat $4.142M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681078623","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681078623?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:50","pubTimestamp":1793883037,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 25 percent increase over losses of $(0.04) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62914485/lexicon-pharmaceuticals-q3-eps-0-03-beats-0-06-estimate-sales-11-250m-beat-4-142m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681020606","title":"Lexicon Pharma Q3 Revenue Declines on Lower Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2681020606","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681020606?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:36","pubTimestamp":1793882202,"startTime":"0","endTime":"0","summary":"Lexicon Pharma Q3 revenue declines on lower milestone paymentsOverviewCardiometabolic drugmaker's Q3 total revenue fell yr/yr, driven by lower milestone and licensing revenue; but net product revenue ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M0NV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681027346","title":"Lexicon Pharmaceuticals Q3 2026 Net Loss Widens 9% to $14 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681027346","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681027346?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:18","pubTimestamp":1793881106,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Q3 2026 net loss widens 9% to $14 millionLexicon Pharmaceuticals’ third-quarter 2026 net loss widened 9% year over year to $14 million.Total revenues fell 20% year over year to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nNDLz966v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681240570","title":"Lexicon Pharmaceuticals Q3 EPS USD -0.03","url":"https://stock-news.laohu8.com/highlight/detail?id=2681240570","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681240570?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:01","pubTimestamp":1793880070,"startTime":"0","endTime":"0","summary":"BRIEF-Lexicon Pharmaceuticals Q3 EPS USD -0.03Nov 05 (Reuters) - Lexicon Pharmaceuticals Q3 product revenue USD 1.181 million.Q3 net income USD -14.005 millionQ3 basic EPS USD -0.03Q3 operating income USD -14.495 millionQ3 operating expenses USD 25.745 million","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXLBS68B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681202717","title":"Lexicon Pharmaceuticals - Zynquista Nda Resubmission Anticipated in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2681202717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681202717?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:00","pubTimestamp":1793880010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXLBS68B:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681024106","title":"Lexicon Pharmaceuticals Q3 Product Revenue USD 1.181 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681024106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681024106?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:00","pubTimestamp":1793880010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXLBS68B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXRX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681078647","title":"Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2681078647","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681078647?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:00","pubTimestamp":1793880000,"startTime":"0","endTime":"0","summary":"Phase 3 SONATA-HCM study substantially overenrolled; top-line data expected Q1 2027 Positive STENO1 safety data strengthens benefit-risk profile for ZYNQUISTA NDA resubmission Phase 1 clinical develop","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3396236/0/en/lexicon-pharmaceuticals-reports-third-quarter-2026-financial-results-and-provides-clinical-updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4531","HCM","BK4007","BK4588","BK4585","032820.KR","BK4139","BK9077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679027054","title":"Lexicon Pharmaceuticals Sets Third-Quarter Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2679027054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679027054?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:33","pubTimestamp":1793277219,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Sets Third-Quarter Results ReleaseLexicon Pharmaceuticals will release third-quarter 2026 financial results on Nov. 5, 2026, before the market opens.A results conference call a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL29yFd9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","NDAQ","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014039.USD","SG9999014021.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","IE00BN0W2W23.USD","BK4007","BK4588","LU0314104364.USD","IE00BKPKM429.USD","BK4139","BK4585","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4112","IE00BQXX3C00.GBP","LU2210150020.SGD","LXRX","IE00BQXX3F31.USD","BCDF","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678174315","title":"Analysts’ Top Healthcare Picks: Anixa Biosciences (ANIX), Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678174315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678174315?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:40","pubTimestamp":1793101220,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Anixa Biosciences (ANIX) and Lexicon Pharmaceuticals...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-anixa-biosciences-anix-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-anixa-biosciences-anix-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX","LU0128526141.USD","BK4139","XBI","BK4585","LABU","XLV","BK4581","ANIX","BK4007","BK4588","HCSG","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678156432","title":"Lexicon Pharmaceuticals, Inc. : Jefferies Cuts Target Price to $1.69 from $2.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2678156432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678156432?lang=en_us&edition=fundamental","pubTime":"2026-10-26 12:47","pubTimestamp":1792990046,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nFWN46C056:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXRX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677397922","title":"Lexicon's Phase 3 Sotagliflozin HCM Trial Exceeds Enrollment Target with 542 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2677397922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677397922?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:33","pubTimestamp":1792758789,"startTime":"0","endTime":"0","summary":"Lexicon's Phase 3 Sotagliflozin HCM Trial Exceeds Enrollment Target With 542 PatientsLexicon Pharmaceuticals reported baseline patient characteristics for its pivotal Phase 3 SONATA-HCM trial of sotag","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL6HQ1fq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2095319765.USD","BK4007","LXRX","SG9999014005.SGD","BK4585","BK4588","SG9999014013.SGD","IE00BQXX3C00.GBP","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","BK4139","SG9999014021.USD","IE00BN0W2V16.EUR","BCDF","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677592288","title":"Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 Sonata-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2677592288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677592288?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:30","pubTimestamp":1792758601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA8ZVXVB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677367902","title":"Lexicon's Sotagliflozin Improves Cardiac Function in Mouse Study of Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2677367902","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677367902?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:31","pubTimestamp":1792585903,"startTime":"0","endTime":"0","summary":"Lexicon's Sotagliflozin Improves Cardiac Function in Mouse Study of Hypertrophic CardiomyopathyLexicon Pharmaceuticals highlighted two published preclinical studies showing sotagliflozin’s favorable e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL7q8pY4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014021.USD","SG9999014005.SGD","LXRX","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","LU0314104364.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","BK4139","LU2210149790.SGD","BK4007","LU2095319765.USD","IE00BN0W2T93.GBP","BCDF","IE00BKPKM429.USD","IE00BQXX3F31.USD","BK4588","IE00BGHQF748.EUR","BK4112","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677718096","title":"Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2677718096","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677718096?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:30","pubTimestamp":1792585800,"startTime":"0","endTime":"0","summary":"-- Preclinical study demonstrates positive effects of sotagliflozin on cardiac function and structure in hypertrophic cardiomyopathy -- -- Second preclinical study shows inhibitory effects of sotaglif","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385524/0/en/lexicon-pharmaceuticals-announces-publication-of-new-research-highlighting-sotagliflozin-s-biological-effects-in-cardiovascular-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HCM","BK4531","BK4139","CSII","BK4585","LXRX","BK4007","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676654407","title":"Cantor Fitzgerald Reaffirms Their Buy Rating on Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2676654407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676654407?lang=en_us&edition=fundamental","pubTime":"2026-10-20 13:45","pubTimestamp":1792475123,"startTime":"0","endTime":"0","summary":"In a report released on October 18, Steven Seedhouse from Cantor Fitzgerald maintained a Buy rating on Lexicon Pharmaceuticals, with a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-reaffirms-their-buy-rating-on-lexicon-pharmaceuticals-lxrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676635419","title":"Mineralys Therapeutics Appoints Kristine Peterson and Lonnel Coats to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2676635419","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676635419?lang=en_us&edition=fundamental","pubTime":"2026-10-20 04:08","pubTimestamp":1792440504,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Appoints Kristine Peterson and Lonnel Coats to BoardMineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its board as it prepares for lorundrostat's potential ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDL8WPKDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042991.SGD","BCDF","RXL","VHT","LU0949170772.SGD","BK4532","LU2210150020.SGD","BMED","BK4585","LXRX","BMY","GDOC","LU1670711040.USD","IHE","TRUH","LU2602419157.SGD","LU2430703178.SGD","LU1989771016.USD","LU2403377893.USD","FHLC","LU0289739699.SGD","LU0472753341.HKD","LU1066051811.HKD","LU1291159041.SGD","LU1674673691.USD","LU2505996509.AUD","SG9999002232.USD","SG9999014013.SGD","LU0234572021.USD","IE000WAW04H5.SGD","LU1868836591.USD","JDOC","LU2756315318.SGD","PJP","LU0070217475.USD","JNJ","NDAQ","IE00BZ1G4Q59.USD","XLV","LU2213496289.HKD","LU2471134952.CNY","LU0306806265.USD","FTXH","MEDX","IYH","IE000F7OJYX1.SGD","LU0426417589.USD","MLYS","IXJ","LU1244550494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252499","title":"Lexicon Pharmaceuticals Shares Rise After Cantor Fitzgerald Initiates With Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252499","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252499?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:55","pubTimestamp":1790621751,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals  shares rose 7.5% in Monday trading after Cantor Fitzgerald initiated coverage of the stock with an overweight rating and a price target of $8.Trading volume stood at over 7.7 million shares, compared with a daily average of about 2.9 million.Price: 1.93, Change: +0.14, Percent Change: +7.52","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670399382","title":"Lexicon Pharma Price Target Announced at $8.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2670399382","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670399382?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:49","pubTimestamp":1790592540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXRX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","LXRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":0.2535},{"period":"1month","weight":0.0114},{"period":"3month","weight":-0.2794},{"period":"6month","weight":-0.11},{"period":"1year","weight":0.2448},{"period":"ytd","weight":0.5478}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.040884},{"month":2,"riseRate":0.423077,"avgChangeRate":-0.046623},{"month":3,"riseRate":0.5,"avgChangeRate":-0.016324},{"month":4,"riseRate":0.461538,"avgChangeRate":0.013505},{"month":5,"riseRate":0.518519,"avgChangeRate":0.041126},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133521},{"month":7,"riseRate":0.481481,"avgChangeRate":0.019303},{"month":8,"riseRate":0.259259,"avgChangeRate":-0.025305},{"month":9,"riseRate":0.333333,"avgChangeRate":0.004544},{"month":10,"riseRate":0.518519,"avgChangeRate":-0.015229},{"month":11,"riseRate":0.407407,"avgChangeRate":-0.03088},{"month":12,"riseRate":0.461538,"avgChangeRate":0.062158}],"exchange":"NASDAQ","name":"Lexicon Pharmaceuticals","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lexicon Pharmaceuticals(LXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lexicon Pharmaceuticals,LXRX,Lexicon Pharmaceuticals股票,Lexicon Pharmaceuticals股票老虎,Lexicon Pharmaceuticals股票老虎国际,Lexicon Pharmaceuticals行情,Lexicon Pharmaceuticals股票行情,Lexicon Pharmaceuticals股价,Lexicon Pharmaceuticals股市,Lexicon Pharmaceuticals股票价格,Lexicon Pharmaceuticals股票交易,Lexicon Pharmaceuticals股票购买,Lexicon Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lexicon Pharmaceuticals(LXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}